Multicenter observational study of the efficacy of sitagliptin in patients at high risk of cardiovascular disease.
Phase of Trial: Phase IV
Latest Information Update: 17 May 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 01 Jul 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 Jun 2011 Planned end date (Jul 2013) added as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record